IL1B and cyst: Other authors reported about the identification of high-risk/malignant lesions by examination of the cyst fluid of IPMNs either by analyzing the MUC expression and cyst fluid cytokine levels (e.g., interleukin-1 beta) or by recognition of atypical cell components [80–83].